Genenta Science SpA ADR(SAEN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 5 at 4:52 PM ET (Korea 11/6 06:52)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.37 | Insider Own | - | Shs Outstand | 23.4M | Perf Week | 4.79% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -13.95% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 2.59% | Short Float | - | Perf Quarter | -50.02% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | -15.67% | Short Ratio | 1.3 | Perf Half Y | 1.48% |
| Sales | 0.00B | P/B | 0.59 | EPS next 5Y | - | ROA | -27.77% | Short Interest | 0.11M | Perf YTD | -56.4% |
| Book/sh | 1.09 | P/C | 0.95 | EPS past 3/5Y | 8.56% -1.23% | ROE | -38% | 52W High | -74.82% ($2.58) | Perf Year | -73.59% |
| Cash/sh | 0.69 | P/FCF | - | Sales past 3/5Y | - | ROIC | -21.2% | 52W Low | 18.13% ($0.55) | Perf 3Y | -87.99% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 29.62% | Gross Margin | - | Volatility(W/M) | 20.57% 10.62% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.16 | EPS Q/Q | 48.49% | Profit Margin | - | RSI (14) | 45.65 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.16 | Sales Q/Q | - | SMA20 | -5.03% ($0.68) | Beta | 0.77 | Target Price | $6.94 |
| Payout | - | Debt/Eq | 0.35 | Earnings | 2026/7/22 | SMA50 | -14.57% ($0.76) | Rel Volume | 1.92 | Prev Close | $0.7 |
| Employees | 9 | LT Debt/Eq | 0.35 | EPS/Sales Surpr. | - | SMA200 | -36.74% ($1.03) | Avg Volume(3M) | 0.08M | Price | $0.65 |
| IPO | 2021/12/15 | Option/Short | No/Yes | Trades | 247 | Volume | 158,709 | Change | -7.19% |
SAENGenenta Science SpA ADR | NASD | Conglomerates 🏭 This is a company based in Milan, Italy. Starting from cell and gene therapy technologies targeting solid tumors, it is shifting its business axis toward becoming an industrial integration company that acquires and bundles small companies in the defense, aerospace, and cybersecurity sectors. It was established in 2014 and is listed on the US Nasdaq in the form of American Depositary Receipts.
Over the past 1 year, on the lower side
75% below its 1-year high.
Traded more than usual. That is 192% of its average volume.
SAEN has a sound balance sheet but weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -88.0%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 2.6%.
Tap to view numbers
It ranks #23 of 28 in the industry
Based on market cap of $31M.
AIAI#22 AIAI Holdings Corp $71M PER - SAEN#23 Genenta Science SpA ADR $31M PER - 
HHS#24 Harte-Hanks Inc $30M PER - 
GPUS#25 Hyperscale Data Inc $28M PER - 
LGPS#26 LogProstyle Inc $14M PER 2.8 
FAQ
What kind of company is SAEN?
SAEN belongs to the Industrials sector and operates in the Conglomerates industry.
What is the market cap of SAEN?
The market cap of SAEN is approximately $31M, ranking 5,027 within its sector.
What is the 52-week high and low for SAEN?
SAEN has recorded a 52-week high of $2.58 and a low of $0.55.
